Alkosign Ltd

Alkosign Ltd has announced the closure of its trading window for dealing in the company's equity shares. This measure is in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015. The window will be closed effective October 1, 2026, and will reopen 48 hours after the financial results for the half-year ended September 30, 2026, are communicated to the stock exchanges. The date for the board meeting to consider these financial results will be announced separately. This disclosure is made as per SEBI's Listing Obligation and Disclosure Requirements Regulations, 2015.

Alkosign Ltd has announced its 6th Annual General Meeting (AGM) scheduled for Tuesday, September 29, 2026, at 12:00 PM IST. The meeting will be held at their registered office in Bhiwandi, Thane. The company has also submitted its Annual Report for the financial year 2025-26, which includes the AGM notice, Director's Report, Management Discussion and Analysis, and financial statements. The Annual Report is being sent to shareholders electronically and is also available on the company's website and the BSE India website.

Alkosign Ltd has submitted its Annual Report for the financial year 2025-26, in compliance with SEBI regulations. The report includes the Notice for the 6th Annual General Meeting (AGM), scheduled for September 29, 2026. The AGM will be held physically at their registered office in Bhiwandi, Thane. The annual report is being disseminated electronically to shareholders and is also available on the company's website and the BSE India website. The report contains various sections including the Directors' Report, Management Discussion and Analysis, financial statements, and auditor's reports.

Alkosign Ltd's Board of Directors met on September 4, 2026, approving several key decisions. These include the re-appointment of Mr. Samir Narendra Shah as Chairman and Managing Director, Mr. Shrenik Kamlesh Shah as Whole-time Director, and Mr. Parshva Vinaykant Doshi, Ms. Seema Ashim Jhaveri, and Mr. Yogesh Ramgopal Gupta as Non-Executive Independent Directors, all for five-year terms subject to shareholder approval. The board also approved the Director's Report for FY26, and the draft notice for the 6th Annual General Meeting scheduled for September 29, 2026. M/s. Dilip Swarnkar & Associates were appointed as Scrutinizers for the AGM.

Alkosign Ltd has announced revised financial results for the year ended March 31, 2026. The revision is due to a typographical error in the previously submitted audited financial figures. The company's Board of Directors approved the audited standalone and consolidated financial results for the half-year and full financial year ended March 31, 2026, at a meeting held on May 29, 2026. Additionally, the Board re-appointed M/s Shah Gupta & Co. Associates as the Internal Auditor for FY 2026-27. The statutory auditors, M/s. K. S. Shah & Co., have issued an unmodified audit opinion on the revised financial results.

Alkosign Ltd's Board of Directors approved the audited standalone and consolidated financial results for the year ended March 31, 2026, during a meeting held on May 29, 2026. The board also approved the re-appointment of M/s Shah Gupta & Co. Associates as the Internal Auditor for the financial year 2026-27. The Statutory Auditors, M/s. K. S. Shah & Co., issued an audit report with an unmodified opinion on the financial results.

Alkosign Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the standalone and consolidated audited financial results for the fiscal year ended March 31, 2026. In compliance with SEBI regulations, the trading window for the company's equity shares has been closed since April 1, 2026, and will remain closed until 48 hours after the financial results are communicated to the stock exchange.

Samir Shah and Persons Acting in Concert (PAC) have acquired a 1.34% stake in Alkosign Ltd through open market purchases. The total shares acquired amount to 29,98,501 out of 2,15,85,000 shares of the company. The acquisition was made in compliance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The shares were purchased between November 2025 and March 2026.

Samir Narendra Shah and Persons Acting in Concert (PACs) have acquired a significant stake in Alkosign Ltd through open market purchases. The total shares acquired amount to 27.78% of the company's total diluted share capital. The acquisition was made in several tranches between November 2025 and March 2026. Samir Narendra Shah purchased 38,250 shares, Shrenik Shah purchased 58,375 shares, and Prisha Shah purchased 2,250 shares. The total equity shares of the company stand at 1,07,92,497 after the acquisition.

Alkosign Ltd has announced the closure of the trading window for dealing in Equity Shares. The closure will be effective from Wednesday, April 01, 2026, and will continue till 48 hours after the communication of the audited financial results for the year ended on March 31, 2026, to the Stock Exchange. The date of the Board meeting for the consideration of these financial results is yet to be intimated to the Stock Exchanges.